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Abstract
Pharmacologic MRI (phMRI) uses functional MRI techniques to provide a non-invasive in vivo
measurement of the hemodynamic effects of drugs. The cerebral blood volume change (ΔCBV)
serves as a surrogate for neuronal activity via neurovascular coupling mechanisms. By assessing
the location and time course of brain activity in mouse mutant studies, phMRI can provide
valuable insights into how different behavioral phenotypes are expressed in differing brain activity
response to drug challenge. In this report, we evaluate the utility of three different intravascular
ultrasmall superparamagnetic iron oxide (USPIO) contrast agents for phMRI using a gradient-echo
technique with temporal resolution of one minute at high magnetic field. The tissue half life of the
USPIOs was studied using a nonlinear detrending model. All three studied USPIOs are candidates
for CBV weighted phMRI-experiments, with r2/r1 ratios ≥ 20 and apparent half-lives ≥ 1.5 h at
the described doses. An echo time of about 10 ms or longer results in a fCNR > 75 after USPIO
injection, with negligible decrease during 1.5 to 2 hours. phMRI experiments were conducted at
7T using cocaine as a psychotropic substance and acetazolamide, a global vasodilator, as a
positive control. Cocaine acts as a dopamine-serotonin-norepinephrine reuptake inhibitor,
increasing extracellular concentrations of these neurotransmitters and thus increasing
dopaminergic, serotonergic and noradrenergic neurotransmission. phMRI indicated that CBV was
reduced in the normal mouse brain after cocaine challenge, with largest effects in nucleus
accumbens, while after acetazolamide the blood volume was increased in both cerebral and extra-
cerebral tissue.
Introduction
Pharmacological magnetic resonance imaging (phMRI) is well suited to monitor drug action
in the brain dynamically and noninvasively; mapping brain systems and networks targeted
by psychoactive drugs (1, 2). phMRI measures the hemodynamic responses to a
pharmacological challenge, and thus probes the activity of neuronal pathways targeted by
the drug based on the neurovascular consequences of changed neuronal (and vascular)
activities (3–5). This technique has the potential to elucidate the underlying changes in
regional brain activities in mouse models of disorders related to altered brain function.
However, small brain size, rapid metabolic rates, susceptibility artifacts, and the need for
anesthesia render functional MRI in mice challenging. In phMRI the sensitivity to functional
changes is enhanced with T2* contrast agents such as ultrasmall superparamagnetic iron
oxide particles (USPIO) that exhibit long circulation times (6). The effect of the particles is
so large that most of the MRI signal arises from the cerebral blood volume (CBV) with
insignificant blood oxygen level dependent (BOLD) or blood flow contributions. Studies
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using this technique are typically performed with rats (4, 5, 7) or nonhuman primates (3),
although there have been a few studies in mice (8–10).
We have adapted the technique to meet the requirements of mouse imaging, balancing
sequence parameters and contrast agent dose to maintain a reasonable signal to noise ratio
(SNR), avoid excessive susceptibility artifacts in the brain regions of interest (ROIs) and
achieve good sensitivity to the CBV change at a time resolution of < 1 minute and spatial
resolution of < 0.2 mm. We optimized USPIO choice and dose to yield a procedure with
short echo times. Three contrast agents were evaluated: P904, a new USPIO from Guerbet
Research (Aulnay-Sous-Bois, France), monocrystalline iron oxide nanoparticle (MION)
(Massachusetts General Hospital, Boston, MA) and MoldayION (BioPAL, MA). Although
this study was focused on mouse imaging, the usefulness of P904 for the CBV weighted
technique was investigated with the idea in mind that this new USPIO may provide useful
properties for clinical use in humans.
A number of important classes of medications used in the treatment of psychiatric disorders
and many drugs of abuse target plasma membrane reuptake transporters for the monoamine
neurotransmitters dopamine, norepinephrine, and serotonin inhibiting the reuptake of the
released neurotransmitters (11). Dopamine systems including cortico-mesolimbic systems
are crucial for normal reward-seeking behavior and are likely to make major contributions to
the development of addiction (12). In the present report, we have used the CBV weighted
phMRI approach to map the hemodynamic response to an acute cocaine challenge in normal
mice.
Material and Methods
Animals
Female C57BL/6J mice were used the in vivo phMRI experiments. Scans with MION
employed 5 animals, those with MoldayION used 4 animals, and those with P904 used 6
animals. All experiments were performed in accordance with protocols approved by the
Institutional Animal Care and Use Committee of the California Institute of Technology.
Contrast agents
MION—Dextran coated monocrystalline iron oxide nanoparticle with a hydrodynamic
diameter ~ 40 nm (13) was purchased from Harvard Medical School (Massachusetts General
Hospital, Boston, MA) at a concentration of 17 mg/ml. A volume of 2 μl MION/g body
weight (35 mg/kg) was introduced via tail vein injection (IV) (N = 5 mice).
MoldayION—The colloidal magnetite MoldayION (diameter ≈ 30 nm) was purchased
from BioPAL (Worcester, MA) at a concentration of 10 mg/ml (14). 2.5 μl/g body weight
(25 mg/kg) was injected IV (N = 4 mice).
P904—P904 (Guerbet Research, Aulnay-Sous-Bois, France) is a research prototype USPIO
with a hydrodynamic diameter of 25 to 30 nm and a glucose derivative coating designed for
macrophage and vascular imaging applications (15). It was provided as a 500 mM (≈ 28 mg/
ml) solution and was diluted to 3 mg/ml and 6 mg/ml in sterile normal saline solution for IV
injection. A volume of ≈ 4.2 μl/g body weight was injected IV resulting in a dose of 15 mg/
kg (N = 4 mice) and 25 mg/kg (N = 2 mice).
Drugs
Cocaine hydrochloride (Sigma-Aldrich, MO) was dissolved in normal saline solution (5 mg/
ml) for IP injection at a dose of 30 mg/kg. The carbonic anhydrase inhibitor and vasodilator
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acetazolamide (Diamox, Bedford Laboratories, OH) was dissolved in normal saline solution
(16 mg/ml) and injected IP at a dose of 160 mg/kg. Cocaine dosage was established in pilot
experiments that did not involve MRI. In these experiments, the electrocardiogram,
respiration and expired CO2 (MicroCapStar CO2 Monitor, IITC Life Science Inc., CA) of
mice were continuously recorded during cocaine intraperitoneal injection (IP). Criteria for
the choice of the cocaine dose were no arousal from anesthesia and stable physiologic
parameters after injection. Behavioral changes have been reported starting at a cocaine dose
of 5 mg/kg IP in conscious mice (16) while cocaine induced seizures start to appear at 70
mg/kg IP. Doses of 20 to 40 mg/kg IP increase striatal and nucleus accumbens dopamine
levels 3-fold in wild type mice (17, 18). Thus, the dose of 30 mg/kg used here is well within
known limits.
In vitro relaxation time measures
The longitudinal T1 and transverse T2 relaxation times of several contrast agent
concentrations (8 different concentrations for MION and P904; 6 for MoldayION) up to 0.3
mg Fe3+/ml (= 5.37 mM Fe3+) in rat plasma at 37°C were measured in a horizontal bore
Bruker Biospec/Avance 7T/30 cm small animal MR system and a vertical bore Bruker
BioSpin Avance DRX500 11.7T/8.9 cm MR system. A spectroscopic inversion recovery
pulse sequence with 12 inversion times and echo time TE = 50 μs, and a Hahn spin-echo
pulse sequence with 12 TE and a repetition time TR > 5T1 were used. Each measurement
was repeated three times. The longitudinal r1- and transverse r2-relaxivities were determined
as the slope of a linear regression.
In vivo phMRI
In vivo MRI experiments were performed at 7T using a custom made 12-rung linear
birdcage RF coil (length 45 mm, inner diameter 26 mm) for transmission and reception. The
mice were positioned prone in a plastic cradle with an integral head mask providing 1.5 to
1.7% isoflurane in N2/O2 70%/30% and incorporated ECG electrodes for the front paws and
tail. Rectal temperature (Opsens OTG-M, Canada) and respiration (BIOPAC Systems, CA)
were monitored continuously. Simultaneous recording of the electrocardiogram during
gradient echo imaging was not always reliable, but the heart rate at the start and end of the
acquisition were compared. The body temperature was maintained between 36 and 38°C
using heated air passed through the RF coil and a cylindrical plastic extension that covered
the mouse body to prevent loss of the warm air. The isoflurane level was adjusted to achieve
respiratory rates of 80 to 120 breaths per minute and was not changed during image
acquisition. The mice were fitted with tail vein catheters for IV USPIO injection and IP
catheters for drug injection. Both catheters had extension lines with total volumes of 200 μl
and were preloaded with USPIO and drug in normal saline solution before positioning the
mouse in the magnet. All USPIO and drugs were injected by flushing the IV/IP catheter with
250 μl saline solution over a duration of 1 minute while the mouse was positioned inside the
scanner. phMRI experiments were begun only after animal temperature (36–38°C),
respiration, and heart rate (500–750 beats per minute) had stabilized. Further, scans were
terminated if physiological parameters strayed outside normal range or anesthesia became
ineffective at low doses.
An autoshiming routine resulted in a 1H linewidth of < 0.13 ppm (FWHM) in a cube of 4 ×
4 × 4 mm3 brain tissue. After obtaining stable physiologic conditions, relative CBV maps
were obtained based on the intravascular susceptibility effect of the USPIO (4, 19).
For each brain, 14 contiguous axial 0.75 mm thick slices with a field of view of 18 × 18
mm2 were acquired from the olfactory bulb to the cerebellum using a 2D multiple gradient
echo sequence with TR = 600 ms, flip angle = 35°, 100 × 100 matrix, spectral line width 60
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kHz, four echoes at TE = 2.5, 6.0, 9.5 and 13 ms, and an acquisition time of 1 minute per
repetition.
Figure 1 illustrates the phMRI protocol: R2* weighted images were acquired for 20 minutes;
20 post-contrast baseline acquisitions were acquired; cocaine was administered IP; 80
minutes of scans were acquired; acetazolamide was administered IP and imaging continued
for another 80 acquisitions. Due to the length of the imaging protocol we used rather short
baseline intervals (20 minutes). In experiments performed to examine the in vivo properties
of the USPIOs only one pharmacological challenge was performed consisting of IP injection
of cocaine or normal saline solution, up to 30 minutes baseline intervals were used and the
CBV was monitored for at least 90 minutes after pharmacological challenge.
MRI data analysis
Pre-contrast and post-contrast images were automatically coregistered with a 2D rigid body
(3 parameters) model using Automated Image Registration (AIR) software (20). Image
analysis was performed with ImageJ (21). No spatial or temporal smoothing was applied to
the data.
ROIs were outlined manually according to a mouse brain atlas (22) on the first echo (TE =
2.5 ms) images of the multiple gradient echo sequence with the help of the images at TE ≥ 6
ms for better visualization of the ventricles and white matter. They were then copied to the
other echoes for signal analysis. Perles-Barbacaru et al (23) shows outlines of the ROIs
analyzed.
For each USPIO, we quantified the signal decrease upon injection and estimated the tissue
washout rate of the contrast agent, both of which determine the sensitivity of the technique
to functional CBV changes. The relative signal decrease upon contrast agent (CA)
administration:
(1)
depends on the relaxivity of the contrast agent and its tissue concentration. These factors
determine the transverse relaxation rate change
(2)
where TE is the echo time, SpreCA is the mean signal intensity prior to contrast agent
injection and SpostCA is the signal intensity averaged over the first five acquisitions after
contrast agent injection (Figure 1).
The apparent tissue washout rate of the contrast agent was estimated by fitting the signal
intensity after contrast agent injection during two time intervals prior to and 60 to 80
minutes after pharmacological challenge (Figure 1) to a two parameter model:
(3)
where SpreCA is defined as above. The fitting parameter κ provides an estimate of the initial
ΔR2* following USPIO injection, while τ is the apparent washout rate of the contrast agent
from the tissue. In this model we assume negligible T1-effects, an instantaneous USPIO
bolus and monoexponential decay in the plasma, since USPIO is confined to the
intravascular compartment. The outer exponential results from the R2* weighting (24). The
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return of the CBV to the pre-challenge value within 60 minutes is an assumption supported
by microdialysis studies in rats ((25), and behavioral studies in mice following IP cocaine
injection (26).
The relative CBV change (ΔCBV) is calculated by assuming a linear relationship between
CBV and ΔR2* (4):
(4)
where S0(t) represents the fit to the signal time-course after contrast agent injection under
resting conditions with no drug challenge (Eq. 3). S(t) refers to the measured signal. We
computed parametric maps of the transverse relaxation rate change κ upon contrast agent
injection, of the apparent tissue washout rate τ and of the ΔCBV after pharmacologic
challenge.
Quantitative analysis of the ΔCBV upon drug injection was also performed on a number of
cerebral ROIs that are thought to form the drug reward circuitry. We analyzed ROIs in the
motor and somatosensory cortex (CTX), nucleus accumbens (ACB), caudate putamen (CP),
hippocampal formation (HPF), thalamic nuclei (TH), hypothalamus (HY) and ventral
tegmental area (VTA). To rule out confounding systemic vascular changes associated with
the pharmacological stimulus and independent of neuronal activity, we also analyzed the
signal change in an extracerebral ROI located in the masseter or temporalis muscle.
The “functional” contrast to noise ratio (fCNR) quantifies the sensitivity of the technique as
a function of time, since it depends on the USPIO washout rate from the tissue. The fCNR is
defined as
(5)
where SpreCA is the pre-contrast baseline signal as defined above, S0 is the modeled signal
recovery using Equation 3 and σt is the temporal standard deviation of the signal. Thus, σt
contains both physical and physiological noise components. To calculate σt, we used data
acquired during the 5 minute interval that followed contrast agent injection (σt of SpostCA,
Figure 1).
The unpaired Student-Test was used to test the significance (P < 0.05) of differences.
Results
During intravenous injection of all three USPIOs, respiratory amplitudes increased and rates
increased to about 160 breaths per minute, but both returned to baseline within one minute.
In phMRI experiments, we administered cocaine intraperitoneally to avoid sudden
hypervolemia and to avoid the body motion that often accompanied intravenous cocaine
administration. An IP dose of 30 mg/kg cocaine transiently reduced and then increased the
respiratory amplitude for 1 to 3 minutes.
Table 1 lists the contrast agent relaxivities measured at 37°C. In all relaxation time
measurements, the linear correlation coefficient of the curve fit was larger than 0.98. Of the
three evaluated USPIOs, P904 had the highest transverse relaxivities. With r2/r1 = 60 at 7T
and r2/r1 = 148 at 11.7T, P904 displayed the most favorable relaxation properties (r2 ≫ r1)
for a R2*-weighted MRI technique.
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Figure 2a shows that MION (35 mg/kg) and MoldayION (25 mg/kg) yield similar regional
signal changes in the caudate putamen (ROI area 3.2 ± 0.2 mm2). Doses of 15 mg/kg of
P904 decreased signal by about half as much. Increasing the P904 dose to 25 mg/kg yielded
a fractional signal decrease of 0.139 ± 0.007, 0.329 ± 0.007, 0.479 ± 0.003 and 0.591 ±
0.003 in the same ROI for TE = 2.5, 6, 9.5 and 13 ms, respectively.
The average fCNR following MION injection was 31.3 ± 6.5, 48.9 ± 9.7, 75.5 ± 6.2, and
112.0 ± 8.8 for TE = 2.5, 6, 9.5 and 13 ms, respectively. Although the signal decrease is
significantly greater at TE = 13 ms than at TE = 9.5 ms, the signal decrease induced by the
MION injection at TE = 9.5 ms comes closest to the optimal value of 1 − e−1 (4). We
therefore analyzed the ΔCBV in the phMRI experiments using the 3rd echo at TE = 9.5 ms,
which displays less macroscopic susceptibility artifact than the 4th echo image at TE = 13
ms. The measured signal decrease not only depends on the USPIO relaxivity and dose, but
also on the tissue region examined. The ΔR2* map in Figure 2b, calculated according to Eq.
2, also represents the relative local CBV, assuming a linear relationship between CBV and
ΔR2* (27).
The fCNR varies only slowly during the pharmacological challenge. In the caudate putamen,
the average apparent tissue half-life τ·ln2 (Figure 3a) was 80 to 90 minutes for 25 mg/kg
P904 and 130 to 160 minutes for 35 mg/kg MION. However there was large inter-individual
variability. MoldayION (25 mg/kg) caused a sustained susceptibility perturbation in tissue
that provided a signal that was practically constant during the duration of the experiment (2
hours post injection). Therefore the tissue washout rate of this USPIO could not be
determined accurately in this experiment. Even at TE = 2.5 ms, the tissue half-life was
estimated to be at least 7 h. The USPIO half-life is dependent on the injected dose, visible in
Figure 3a comparing two P904 doses.
The maps in Figure 3b and c show that the apparent tissue half-life of the USPIO is region
specific implying that the signal in each voxel or region needs to be detrended individually.
Global detrending of the signal time course using an average apparent washout rate would
greatly compromise the quantification of the hemodynamic changes under study. Therefore,
prior to quantitative analysis, the signal intensity after contrast agent injection, S(t), was
detrended using Eq. 3 to eliminate the effect of contrast agent washout. Equation 3 results in
more accurate fits to the signal from individual voxels compared to a constrained
exponential model (28) and compared to a two parameter exponential model in which only
SpreCA is constrained while SpostCA is a fitting parameter (Figure 4). Both models result in
practically identical S0 for a signal averaged over larger ROIs or for longer TE (higher
fCNR), conditions under which SpostCA for the constrained exponential model (28) can be
accurately determined.
Neither intraperitoneal nor intravenous injection of saline induced any CBV changes (Figure
5a). A spatially and temporally dependent CBV change was observed in cerebral tissue of
mice treated with cocaine. Moreover, there was no measurable effect on extra-cerebral
vasculature (Figure 5b). Cocaine induced a CBV decrease (Figure 6) that lasted 40 to 60
minutes with regional differences in amplitude and response time. The largest response
amplitudes were observed in ventral and dorsal striatum. To validate the vascular origin of
the signal change, we used the carbonic anhydrase inhibitor acetazolamide to dilate cerebral
vessels directly. The ΔCBV in response to acetazolamide was slower and more variable
between animals but consistently positive (Figure 5b and 6a). As expected, a blood volume
increase in extracerebral tissue was also observed in response to acetazolamide (Figure 5b).
Figure 6b shows coronal ΔCBV maps from one representative animal in 10 minute intervals
before and after the drug challenges. For each map, five time points (5 minutes) were
averaged. From these maps, one can see that the striatum, and in particular the ventral
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striatum/nucleus accumbens, exhibited the strongest response to cocaine. This response
lasted more than 45 minutes. Substantial cocaine-induced CBV changes in the frontal cortex
returned to baseline more rapidly. As expected, the CBV increase due to acetazolamide was
more uniform across brain regions than that noted for cocaine.
Discussion
Several advantages of the CBV technique have been discussed elsewhere (1, 4, 7, 29).
Compared to BOLD imaging, the CBV weighted signal origin is better characterized.
Increased fCNR can be achieved even at high magnetic fields (7). ΔCBV assessments after
pharmacological challenges provide quantitative parameters that can be compared between
individual mice, because they are normalized to the ΔR2* drop induced by the USPIO
injection prior to the pharmacological challenge. Experimental variations in USPIO dosage
or relaxivity or in total mouse blood volume do not impact ΔCBV values, although they do
influence the fCNR and thus the sensitivity of the measurement.
In mice, gradient echo acquisitions are less frequently used than T2-weighted spin echo
acquisitions, because susceptibility artifacts generated at tissue air interfaces have a larger
impact relative to the small brain size impeding signal analysis in particular brain regions.
However, gradient echo acquisitions are potentially more sensitive to the T2*-shortening
effect of USPIO, hereby increasing the fCNR. To improve the sensitivity of the spin echo
technique to vascular changes high contrast agent doses in the order of 1 mmol/kg (50 – 70
mg Fe/kg) were used in some studies (30, 31). Furthermore, it has been shown that spin echo
techniques underestimate the cerebrovascular response when using USPIOs (32). In this
study, we therefore aimed at establishing a fast gradient echo acquisition protocol and at
optimizing the echo time in order to achieve a good fCNR without excessive susceptibility
artifacts at the anatomical locations of interest.
All three USPIO have high r2/r1 ratios and are suitable contrast agents for CBV weighted
phMRI exploiting the transverse relaxation rate changes. Both the signal decrease and the
apparent tissue half-life are dose dependent. For doses above 25 mg/kg P904 or MoldayION
and 35 mg/kg MION, we achieved a satisfactory fCNR. With apparent tissue half-lives of at
least 1.5 hours at these doses, all three USPIO are appropriate for monitoring sustained
hemodynamic responses to pharmacological stimuli that benefit from relatively constant
fCNR over time.
The given tissue half-lives only approximately reflect the blood half-lives of the USPIO
because the signal drop and signal change over time are exponential functions of the USPIO
concentration in any voxel. This issue is further complicated by T1 relaxation effects.
However, in an ROI containing a very small blood volume fraction (~ 3%), the USPIO
concentration in the ROI is relatively low and the signal drop is approximately proportional
to the contrast agent concentration. Under these conditions, the half-life of the tissue signal
recovery can be used to estimate the USPIO blood half-life. Although the apparent tissue
half-lives of the contrast agents are not significantly different at the chosen echo times, there
is a tendency toward increased values at longer echo times, best visible for the lower P904
dose. The echo time dependency represents a complete suppression of the intravascular
signal after USPIO injection that masks the gradual decrease in the tissue relaxation rates
based on contrast agent washout. Although the acquisition with the shortest echo time would
give the closest estimation of the USPIO blood half-life, this measure has a low fCNR.
These experiments show the advantage of using a high USPIO dose achieving signal
saturation at a particular TE in addition to a prolonged blood half-life. Although our
example below employs dynamic imaging with a time resolution of 1 minute, it is possible
to achieve true steady state imaging for up to 30 minutes without any detectable signal
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change due to contrast agent washout from the blood pool using TE ≥ 9.5 ms with contrast
agent doses above 25 mg/kg P904 or MoldayION. This will be important in many
applications that require long acquisition times, such as 3D imaging.
Probing brain response to psychotropic drugs is an important and revealing application of
neuroimaging (33) in general and phMRI (2, 34), in particular. The cortico-mesolimbic
dopaminergic circuit is thought to mediate the rewarding effects of many drugs of abuse,
including cocaine. In our example using cocaine challenge in normal mice, we observed the
largest negative responses in the nucleus accumbens, followed by caudate putamen and
frontal and parietal cortex; all structures with dopaminergic innervations that are important
for reward circuit activities (33). The negative ΔCBV response to cocaine challenge is rapid
(~15 min) throughout the reward circuit, but relatively long lasting (~45 minutes). To ensure
that these measurements inform about neuroactivity we performed a negative and a positive
control experiment. To demonstrate that phMRI directly measures changes in blood volume,
we examined vascular response to acetezolamide, a potent vasodilator (35). As expected, in
this positive control experiment, phMRI indicates that increased cerebral and extra-cerebral
blood volume changes are induced by injection of the vasodilator. In a negative control
experiment we determined muscle tissue blood volume response to cocaine simultaneously
with the cerebral blood volume response to cocaine. Any significant systemic effect of
cocaine injection would have resulted in a signal change in muscle tissue, which was not
observed. Our findings suggest that the measured CBV change in the current study is
independent of systemic effects of the drug. However, the possibility of cocaine interfering
directly with the microvascular mechanisms that give rise to the phMRI signal cannot be
excluded (23). Various studies have also shown that a drug can have opposite effects
depending on the species, the mouse strain, the age, and on various experimental conditions,
such as the choice of anesthesia (see references in (23)).
The mechanism for the ΔCBV response to cocaine is complex involving other
neurotransmitters and downstream consequences of the effects produced by cocaine.
Comparing maps of the ΔCBV response in monoamine transporter and monoamine receptor
knock out mice with normal mice will provide significant insight into the mechanisms of
action of cocaine and other drugs of abuse.
Conclusion
In this study we have adapted phMRI methodology to meet the requirements of in vivo
mouse brain imaging. We optimized USPIO choice and dose to yield a procedure with short
echo times and evaluated three contrast agents: P904, a new USPIO from Guerbet Research
(Aulnay-Sous-Bois, France), monocrystalline iron oxide nanoparticle (MION)
(Massachusetts General Hospital, Boston, MA) and MoldayION (BioPAL, MA). All three
studied USPIOs are candidates for CBV weighted phMRI-experiments, with r2/r1 ratios ≥
20 and apparent half-lives ≥ 1.5 h at the described doses. An echo time of about 10 ms or
longer results in a fCNR > 75 after USPIO injection, with negligible decrease during 1.5 to 2
hours as shown in Figure 5a).
We have applied the phMRI protocol to map the hemodynamic response to cocaine
demonstrating the applicability of the CBV weighted phMRI technique to mapping
hemodynamic effects of centrally acting drugs in mice. The technique is minimally invasive
and provides good functional sensitivity. The negative ΔCBV response to cocaine challenge
is rapid (~15 min) throughout the reward circuit. The largest responses to cocaine
(−20%ΔCBV) are seen in the nucleus accumbens. Thus these results emphasize the
importance of the nucleus accumbens at early as well as later stages of drug exposure. We
also note that the mechanisms underlying the CBV changes may not be exclusively specific
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to neuroactivation, and necessitate further investigation to separate more direct influences on
vasculature from those that are specifically neurovascular.
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Abbreviations
MRI Magnetic Resonance Imaging
phMRI pharmacological Magnetic Resonance Imaging
CBV cerebral blood volume
ΔCBV change in cerebral blood volume
IP intraperitoneal injection
IV intravenous injection
USPIO ultrasmall superparamagnetic iron oxide particles
BOLD blood oxygen level dependent
SNR signal to noise ratio
CNR contrast to noise ratio
fCNR functional contrast to noise ratio
SEM standard error of the mean
TE echo time
T1 longitudinal relaxation time
T2 transverse relaxation time
ECG electrocardiogram
mm millimeter
mg milligram
μl microliter
μs microsecond
nm nanometer
ROI region of interest
MION monocrystalline iron oxide nanoparticles
FWHM full width at half maximum
AIR Automated Image Registration
CA contrast agent
CTX somatosensory cortex
ACB nucleus accumbens
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CP caudate putamen
HPF hippocampal formation
TH thalamic nuclei
HY hypothalamus
VTA ventral tegmental area
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Figure 1.
Experimental phMRI protocol: gradient echo images were acquired continuously with a time
resolution of 1 minute. USPIO was delivered IV to sensitize the MR signal to CBV followed
by cocaine (30 mg/kg IP) and the vasodilator acetazolamide (160 mg/kg IP). SpreCA. is the
constant baseline signal before contrast agent injection; SpostCA is the average of five
consecutive signals acquired immediately after contrast agent injection; and S(t) is the time
dependent CBV-weighted signal after contrast agent injection. The time intervals marked as
washout were used to detrend the signal and to derive the contrast agent washout rate.
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Figure 2.
a) Average signal decrease ± standard error of the mean (SEM) in cerebral tissue (caudate
putamen, 3.2 ± 0.2 mm2) after IV USPIO. b) Representative coronal ΔR2*-map (bregma + 1
mm, 0.18 × 0.18 × 0.75 mm3 voxel size) resulting from 35 mg/kg MION injection that is
proportional to the local CBV. Scale bar is 1 mm. Intensity scale is in s−1.
Perles-Barbacaru et al. Page 14
NMR Biomed. Author manuscript; available in PMC 2013 April 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 3.
a) Average apparent USPIO half-life (τ·ln2) ± SEM in minutes in the caudate putamen.
Apparent tissue half-life of MoldayION is not shown, but was estimated to be > 7 hr (cf.
main text). b and c) Representative maps of the apparent tissue half-life for 35 mg/kg MION
(b) and for 25 mg/kg P904 (c). Black pixels represent failed fit. Intensity scale is in minutes.
Scale bar is 1 mm.
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Figure 4.
Comparison of the nonlinear two parameter fit (Eq. 3) and an exponential constrained two
parameter fit (28) for voxelwise detrending of high and low fCNR data. The four maps and
the histograms show a basic parameter of the goodness of fit (R2) for 1446 voxels located in
brain tissue. Black voxels represent failed fit. The intensity scale is 0 ≤ R2 ≤ 1.
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Figure 5.
a) Typical signal time course from a ROI in the ACB (area 2.5 mm3) in a single mouse.
Error bars show the standard deviation of the signal within the ROI. IV injection of normal
saline solution (10 μl/g) induces no hemodynamic effect in brain tissue. b) Effect of IP
cocaine (30 mg/kg) and acetazolamide (160 mg/kg) on the time course of the ΔCBV in
cerebral (ACB) and in extra-cerebral tissue (muscle). Injection of cocaine leads to a CBV
decrease in cerebral tissue without hemodynamic effect in extracerebral tissue, while
vasodilation is observed in cerebral and extra-cerebral tissues after acetazolamide injection.
Error bars show the standard deviation (N = 5).
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Figure 6.
a) ROI analysis shows that injection of 30 mg/kg cocaine IP causes local decreases in the
CBV in mice, while injection of 160 mg/kg acetazolamide IP causes global vasodilation.
Typically, the ΔCBV response peaks at 15 min after cocaine injection, while the
vasodilatory effect of acetazolamide is slower and more variable. The error bars represent
the standard error of the mean (N = 5). For each time point the signal was averaged over 5
minutes. b) Representative coronal maps (bregma + 1 mm) of the CBV change (ΔCBV)
averaged over 5 minutes at different time-points after IP cocaine injection. The strongest and
fastest CBV changes occur in ventral striatum/ACB after both drugs. Differential CBV
changes can be observed in dorsal striatum and frontal cortex. The three ROIs outlined on
the leftmost map are CTX, CP and ACB (dorsal to ventral). Intensity scale is fractional
ΔCBV. Scale bar is 2 mm.
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Table 1
in vitro longitudinal and transverse relaxivities in s−1mM−1 in rat plasma at 37°C
7T 11.7T
MION r1 2.38 ± 0.03 1.12 ± 0.01
r2 48. 7 ± 1.2 60.6 ± 0.6
P904 r1 1.42 ± 0.02 0.64 ± 0.01
r2 85 ± 1.3 94.7 ± 0.8
MoldayION r1 1.99 ± 0.01 1.01 ± 0.02
r2 67.5 ± 0.4 81. ± 1.5
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